The impact of dose-escalated RT on ADT in patients with intermediate risk prostate cancer

被引：0
作者：
Onal, Cem [1 ,2 ]
Guler, Ozan Cem [1 ]
Erbay, Gurcan [3 ]
Elmali, Aysenur [2 ]
机构：
[1] Baskent Univ, Dept Radiat Oncol, Fac Med, Adana, Turkiye
[2] Baskent Univ, Dept Radiat Oncol, Fac Med, Ankara, Turkiye
[3] Baskent Univ, Dept Radiol, Fac Med, Adana, Turkiye
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
ADT; Prostate cancer; Radiotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
126
引用
收藏
页码：S2293 / S2294
页数：2
相关论文
共 50 条
  • [41] Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer
    Amer, AM
    Mott, J
    Mackay, RI
    Williams, PC
    Livsey, J
    Logue, JP
    Hendry, JH
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01): : 199 - 207
  • [42] Role of Androgen-Deprivation Therapy Remains Uncertain for Intermediate-Risk Patients When Using Dose-Escalated Radiotherapy
    Kollmeier, Marisa A.
    McBride, Sean
    Gorovets, Daniel
    Zelefsky, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32)
  • [43] Image-guided dose-escalated radiation therapy for localized prostate cancer with helical tomotherapy
    Barelkowski, Tomasz
    Wust, Peter
    Kaul, David
    Zschaeck, Sebastian
    Wlodarczyk, Waldemar
    Budach, Volker
    Ghadjar, Pirus
    Beck, Marcus
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (03) : 229 - 242
  • [44] Feasibility of and rectal dosimetry improvement with the use of SpaceOAR® hydrogel for dose-escalated prostate cancer radiotherapy
    van Gysen, Kirsten
    Kneebone, Andrew
    Alfieri, Florencia
    Guo, Linxin
    Eade, Thomas
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2014, 58 (04) : 511 - 516
  • [45] Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy
    Berlin, Alejandro
    Murgic, Jure
    Hosni, Ali
    Pintilie, Melania
    Salcedo, Adriana
    Fraser, Michael
    Kamel-Reid, Suzanne
    Zhang, Jingbin
    Wang, Qiqi
    Ch'ng, Carolyn
    Deheshi, Samineh
    Davicioni, Elai
    van der Kwast, Theodorus
    Boutros, Paul C.
    Bristow, Robert G.
    Chua, Melvin L. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (01): : 84 - 91
  • [46] ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer
    Rodda, Sree
    Morris, W. James
    Hamm, Jeremy
    Duncan, Graeme
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (03): : 581 - 589
  • [47] Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy
    Shilkrut, Mark
    McLaughlin, Patrick W.
    Merrick, Gregory S.
    Vainshtein, Jeffrey M.
    Hamstra, Daniel A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (02): : 181 - 188
  • [48] Reducing radiation-associated toxicity using online image guidance (IGRT) in prostate cancer patients undergoing dose-escalated radiation therapy
    Becker-Schiebe, Martina
    Abaci, Ali
    Ahmad, Tahera
    Hoffmann, Wolfgang
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2016, 21 (03) : 188 - 194
  • [49] Late rectal and urinary toxicity from conformal, dose-escalated radiation therapy for prostate cancer: A prospective study of 402 patients
    Lin, C.
    Turner, S.
    Mai, T.
    Kneebone, A.
    Gebski, V.
    AUSTRALASIAN RADIOLOGY, 2007, 51 (06): : 578 - 583
  • [50] THE PERCENT OF POSITIVE BIOPSY CORES IMPROVES PREDICTION OF PROSTATE CANCER-SPECIFIC DEATH IN PATIENTS TREATED WITH DOSE-ESCALATED RADIOTHERAPY
    Qian, Yushen
    Feng, Felix Y.
    Halverson, Schuyler
    Blas, Kevin
    Sandler, Howard M.
    Hamstra, Daniel A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03): : E135 - E142
12345